OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 11:14  – Posting: # 20101
Views: 2,998

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
20,799 posts in 4,354 threads, 1,445 registered users;
online 16 (1 registered, 15 guests [including 7 identified bots]).
Forum time: 10:38 CEST (Europe/Vienna)

If a man will begin with certainties, he will end in doubts;
but if he will be content to begin with doubts,
he will end in certainties.    Francis Bacon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5